|
1
|
Lemmens K, Segers VF, Demolder M and De
Keulenaer GW: Role of neuregulin-1/ErbB2 signaling in
endothelium-cardiomyocyte crosstalk. J Biol Chem. 281:19469–19477.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Odiete O, Hill MF and Sawyer DB:
Neuregulin in cardiovascular development and disease. Circ Res.
111:1376–1385. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rupert CE and Coulombe KL: The roles of
neuregulin-1 in cardiac development, homeostasis, and disease.
Biomark Insights. 10 Suppl 1:S1–S9. 2015.
|
|
4
|
Hedhli N, Kalinowski A and S Russell K:
Cardiovascular effects of neuregulin-1/ErbB signaling: Role in
vascular signaling and angiogenesis. Curr Pharm Des. 20:4899–4905.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hedhli N and Russell KS: Cytostatic drugs,
neuregulin activation of erbB receptors and angiogenesis. Curr
Hypertens Rep. 12:411–417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Russell KS, Stem DF, Polverini PJ and
Bender JR: Neuregulin activation of ErbB receptors in vascular
endothelium leads to angiogenesis. Am J Physiol. 277:H2205–H2211.
1999.PubMed/NCBI
|
|
7
|
Hedhli N, Dobrucki LW, Kalinowski A,
Zhuang ZW, Wu X, Russell RR III, Sinusas AJ and Russell KS:
Endothelial-derived neuregulin is an important mediator of
ischaemia-induced angiogenesis and arteriogenesis. Cardiovasc Res.
93:516–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiao J, Li B, Zheng Z, Wang M, Peng J, Li
Y and Li Z: Therapeutic effects of neuregulin-1 gene transduction
in rats with myocardial infarction. Coron Artery Dis. 23:460–468.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Karamysheva AF: Mechanisms of
angiogenesis. Biochemistry (Mosc). 73:751–760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng Z, Gui C, Nong Q, Du F and Zhu L:
Serum neuregulin-1β levels are positively correlated with VEGF and
Angiopoietin-1 levels in patients with diabetes and unstable angina
pectoris. Int J Cardiol. 168:3077–3079. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yonezawa M, Wada K, Tatsuguchi A, Akamatsu
T, Gudis K, Seo T, Mitsui K, Nagata K, Tanaka S, Fujimori S and
Sakamoto C: Heregulin-induced VEGF expression via the ErbB3
signaling pathway in colon cancer. Digestion. 80:215–225. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iivanainen E, Paatero I, Heikkinen SM,
Junttila TT, Cao R, Kint P, Jaakkola PM, Cao Y and Elenius K:
Intra- and extracellular signaling by endothelial neuregulin-1. Exp
Cell Res. 313:2896–2909. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakaoka Y, Nishida K, Narimatsu M, Kamiya
A, Minami T, Sawa H, Okawa K, Fujio Y, Koyama T, Maeda M, et al:
Gab family proteins are essential for postnatal maintenance of
cardiac function via neuregulin-1/ErbB signaling. J Clin Invest.
117:1771–1781. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hedhli N, Huang Q, Kalinowski A, Palmeri
M, Hu X, Russell RR and Russell KS: Endothlium-derived neuregulin
protects the heart against ischemic injury. Circulation.
123:2254–2262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuramochi Y, Cote GM, Guo X, Lebrasseur
NK, Cui L, Liao R and Sawyer DB: Cardiac endothelial cells regulate
reactive oxygen species-induced cardiomyocyte apoptosis through
neuregulin-1beta/erbB4 signaling. J Biol Chem. 279:51141–51147.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ky B, Kimmel SE, Safa RN, Putt ME,
Sweitzer NK, Fang JC, Sawyer DB and Cappola TP: Neuregulin-1 beta
is associated with disease severity and adverse outcomes in chronic
heart failure. Circulation. 120:310–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Geisberg CA, Wang G, Safa RN, Smith HM,
Anderson B, Peng XY, Veerkamp B, Zhao DX, Blakemore D, Yu C and
Sawyer DB: Circulating neuregulin-1β levels vary according to the
angiographic severity of coronary artery disease and ischemia.
Coron Artery Dis. 22:577–582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kalinowski A, Plowes NJ, Huang Q,
Berdejo-Izquierdo C, Russell RR and Russell KS: Metalloproteinase
dependent cleavage of neuregulin and autocrine stimulation of
vascular endothelial cells. Faseb J. 24:2567–2575. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lemmens K, Doggen K and De Keulenaer GW:
Role of neuregulin-1/ErbB signaling in cardiovascular physiology
and disease: Implications for therapy of heart failure.
Circulation. 116:954–960. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reiss Y, Droste J, Heil M, Tribulova S,
Schmidt MH, Schaper W, Dumont DJ and Plate KH: Angiopoietin-2
impairs revascularization after limb ischemia. Circ Res. 101:88–96.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lok JL, Sardi SP, Guo S, Besancon E, Ha
DM, Rosell A, Kim WJ, Corfas G and Lo EH: Neuregulin-1 signaling in
brain endothelial cells. J Cereb Blood Flow Metab. 29:39–43. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao YY, Sawyer DR, Baliga RR, Opel DJ,
Han X, Marchionni MA and Kelly RA: Neuregulins promote survival and
growth of cardiac myocytes. Persistence of erbb2 and erbb4
expression in neonatal and adult ventricular myocytes. J Biol Chem.
273:10261–10269. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li B, Xiao J, Li Y, Zhang J and Zeng M:
Gene transfer of human neuregulin-1 attenuates ventricular
remodeling in diabetic cardiomyopathy rats. Exp Ther Med.
6:1105–1112. 2003. View Article : Google Scholar
|
